Skip to main content
logo
SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India flag India · Delayed Price · Currency is INR
224.50
+9.53 (4.43%)
Aug 8, 2025, 3:30 PM IST

SolarWinds Revenue

In the fiscal year ending March 31, 2025, SMS Pharmaceuticals had annual revenue of 7.83B INR with 10.36% growth. SMS Pharmaceuticals had revenue of 2.48B in the quarter ending March 31, 2025, with 0.98% growth.

Revenue
7.83B
Revenue Growth
+10.36%
P/S Ratio
2.43
Revenue / Employee
6.54M
Employees
1,197
Market Cap
19.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20257.83B734.85M10.36%
Mar 31, 20247.09B1.87B35.86%
Mar 31, 20235.22B21.77M0.42%
Mar 31, 20225.20B-433.03M-7.69%
Mar 31, 20215.63B1.49B35.93%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare80.96B
Aurobindo Pharma320.25B
Revenue Rankings

SMS Pharmaceuticals News

More News